Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

175.29
+0.59000.34%
Post-market: 175.290.00000.00%19:56 EDT
Volume:5.43M
Turnover:952.11M
Market Cap:45.39B
PE:-12.33
High:175.82
Open:174.45
Low:174.04
Close:174.70
52wk High:176.60
52wk Low:133.73
Shares:258.92M
Float Shares:258.92M
Volume Ratio:0.55
T/O Rate:2.10%
Dividend:2.53
Dividend Rate:1.45%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.32
PE(LYR):-12.33

Loading ...

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
13 hours ago

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
14 hours ago

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
14 hours ago

Sagimet Reiterated as Buy on De-Risked Acne Program and Clearer Regulatory Path; $29 Price Target Maintained

TIPRANKS
·
Yesterday

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Yesterday

Decent Holding Provides Operational Update: Community Healthcare Network Expands to 623 Centers and Over 210,000 Paid Members

GlobeNewswire
·
Yesterday

Analysts’ Top Healthcare Picks: Dyne Therapeutics (DYN), Universal Health (UHS)

TIPRANKS
·
Yesterday

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Yesterday

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Chip Stocks Recover

MT Newswires Live
·
Yesterday

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Yesterday

China's Shandong Xinhua Profit Drops on Domestic, International Competition

Reuters
·
Yesterday

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
Yesterday

Austar Lifesciences H1 Profit Drops on Higher R&D Spending

Reuters
·
Yesterday

WuXi Biologics H1 Net Profit up on Margin Expansion

Reuters
·
Yesterday

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Yesterday

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
Yesterday

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
Yesterday

YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

GlobeNewswire
·
Yesterday

Incannex Begins Phase 2 DReAMzz Trial for IHL-42X

TIPRANKS
·
Yesterday